Kendall Capital Management Gilead Sciences, Inc. Transaction History

Kendall Capital Management

$316 Million
Q3 2024

A detailed history of Kendall Capital Management transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Kendall Capital Management holds 8,382 shares of GILD stock, worth $740,968. This represents 0.22% of its overall portfolio holdings.

Number of Shares

8,382

Previous 7,317 14.56%

Holding current value

$740,968

Previous $502,000 39.84%

% of portfolio

0.22%

Previous 0.17%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$66.59 - $83.99 $70,918 - $89,449	1,065 Added 14.56%	8,382 $702,000
Q2 2024 Aug 12, 2024	BUY	$63.15 - $72.88 $233,970 - $270,020	3,705 Added 102.57%	7,317 $502,000
Q1 2024 May 10, 2024	BUY	$71.58 - $87.29 $1,789 - $2,182	25 Added 0.7%	3,612 $264,000
Q3 2023 Oct 31, 2023	BUY	$73.94 - $80.67 $66,176 - $72,199	895 Added 33.25%	3,587 $269,000
Q2 2023 Jul 28, 2023	BUY	$76.01 - $86.7 $204,618 - $233,396	2,692 New	2,692 $207,000
Q2 2021 Jul 30, 2021	SELL	$63.47 - $69.35 $198,343 - $216,718	-3,125 Closed	0 $0
Q1 2021 May 05, 2021	SELL	$60.0 - $68.46 $25,500 - $29,095	-425 Reduced 11.97%	3,125 $202,000
Q4 2020 Feb 08, 2021	SELL	$56.65 - $64.55 $9,913 - $11,296	-175 Reduced 4.7%	3,550 $207,000
Q3 2020 Oct 22, 2020	SELL	$62.1 - $78.08 $10,867 - $13,664	-175 Reduced 4.49%	3,725 $235,000
Q2 2020 Jul 30, 2020	SELL	$72.34 - $84.0 $1,085 - $1,260	-15 Reduced 0.38%	3,900 $300,000
Q4 2019 Jan 24, 2020	SELL	$61.62 - $67.78 $12,200 - $13,420	-198 Reduced 4.81%	3,915 $254,000
Q2 2019 Aug 09, 2019	SELL	$61.87 - $69.38 $3,217 - $3,607	-52 Reduced 1.25%	4,113 $278,000
Q1 2019 May 08, 2019	SELL	$62.53 - $70.05 $30,014 - $33,624	-480 Reduced 10.33%	4,165 $271,000
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $102,978 - $134,379	-1,701 Reduced 26.8%	4,645 $291,000
Q3 2018 Oct 29, 2018	SELL	$71.28 - $78.92 $152,824 - $169,204	-2,144 Reduced 25.25%	6,346 $490,000
Q2 2018 Jul 27, 2018	SELL	$64.88 - $75.68 $202,879 - $236,651	-3,127 Reduced 26.92%	8,490 $601,000
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $151,143 - $184,260	-2,075 Reduced 15.15%	11,617 $876,000
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $974,185 - $1.14 Million	13,692	13,692 $981,000

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kendall Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Kendall Capital Management with notifications on news.

Account

Kendall Capital Management Gilead Sciences, Inc. Transaction History